Orris

Antibiotic stewardship

Reading File
Finding Sources
Searching PubMed

"antibiotic stewardship" AND outcomes

Searching the Web

antibiotic stewardship programs 2025 2026 guidelines key principles

Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Now I have comprehensive content from multiple authoritative textbooks. Here is a thorough overview of antibiotic stewardship:

Antibiotic Stewardship

Definition and Goals

Antibiotic stewardship (AS) describes the practice of promoting the selection of the appropriate drug, dosage, route, and duration of antimicrobial therapy. The four core goals of any stewardship program (ASP) are:
  1. Improve patient care through appropriate antimicrobial use
  2. Preserve a vital resource by curbing resistance within patient populations
  3. Reduce adverse effects (toxicity, C. difficile infection, superinfections)
  4. Control costs - including drug expenditure and healthcare resource use
  • Harrison's Principles of Internal Medicine 22E (2025), p. 1222

Why It Matters

In most developed countries, ~85% of total antibiotic use occurs in the outpatient setting, yet stewardship has historically been concentrated in hospitals. Substantial amounts of antimicrobial prescribing remain inappropriate, and the prevalence of multidrug-resistant bacteria continues to rise. Six bacterial hospital-onset AMR infections increased by a combined 20% during the COVID-19 pandemic and remained above pre-pandemic levels.

The ASP Team (Multidisciplinary)

A successful program typically includes:
  • Infectious disease physicians
  • Clinical pharmacists (ideally with ID specialty training, serving as co-leaders)
  • Clinical microbiologists
  • Hospital epidemiologists
  • Infection prevention and control practitioners
  • Information systems specialists

The CDC's 7 Core Elements of Hospital ASPs

Codified in 2014 and updated in 2019, these form the standard framework for hospital programs:
Core ElementDescription
1. Leadership CommitmentHospital administration dedicates human, financial, and IT resources; supports dedicated time for program leads
2. AccountabilityA physician leader and pharmacist co-leader are formally appointed; responsible for program management and outcomes
3. Pharmacy ExpertiseA pharmacist with antibiotic pharmacology expertise co-leads implementation efforts
4. ActionConcrete interventions are implemented (see strategies below)
5. TrackingAntibiotic use monitored as days of therapy (DOT) per 1,000 patient-days; C. difficile rates, resistance patterns, and adverse drug events tracked
6. ReportingRegular updates on antibiotic use and resistance to prescribers, pharmacists, nurses, and leadership
7. EducationAnnual education for all health care workers; patient and family education
  • Red Book 2021 (AAP Committee on Infectious Diseases), p. 1328
  • Goldman-Cecil Medicine, Table 259.2
  • Tietz Textbook of Laboratory Medicine 7th Ed., Box 83.3

Core Outpatient Stewardship Elements (CDC, updated 2026)

Since ~85% of antibiotic use is outpatient, the CDC published outpatient-specific elements in 2016 (updated in 2026 to emphasize health system leadership):
  1. Commitment to improving antibiotic prescribing
  2. Action - Implement at least one policy or practice to improve prescribing and assess its effectiveness
  3. Tracking and Reporting - Monitor prescribing and provide feedback
  4. Education - Provide educational resources to clinicians and patients
  • Harrison's Principles of Internal Medicine 22E (2025), p. 296

Key ASP Strategies and Interventions

Primary Strategies (best evidence)

1. Prospective Audit with Feedback
  • An ID physician or pharmacist reviews orders for broad-spectrum agents (e.g., carbapenems, daptomycin) on a regular basis for appropriateness
  • "Handshake stewardship" is an intensive form involving face-to-face feedback and discussion
  • Has reduced broad-spectrum drug use and C. difficile infection rates in multiple studies
2. Formulary Restriction
  • A limited set of antimicrobials is included in the hospital formulary to prevent indiscriminate use
  • Reduces unnecessary drug expenditure
3. Preauthorization
  • Clinicians must obtain approval before using restricted agents
  • Ensures high-impact drugs are used only when indicated

Additional Interventions

  • IV-to-oral (IVPO) conversion - Transition patients from IV to oral antibiotics as soon as clinically safe; reduces complications, length of stay, and cost
  • Clinical decision support (CDS) - EMR-based order sets, bug-drug mismatch alerts, real-time critical culture result alerts
  • Antibiotic timeout - Reassess all antibiotic orders at 48-72 hours with new culture and clinical data; narrow spectrum, adjust dose, or discontinue
  • Dose optimization - Pharmacokinetic/pharmacodynamic (PK/PD) monitoring for aminoglycosides and vancomycin
  • Peer comparison and audit-feedback - Particularly effective in outpatient settings; showing a prescriber their rates vs. peers ("nudge" approach)
  • Communication training - Most effective when it includes clear diagnosis, explaining natural illness course, and identifying red-flag symptoms
  • Harrison's Principles of Internal Medicine 22E (2025), p. 1223
  • Tietz Textbook of Laboratory Medicine 7th Ed., p. 3322-3335

Duration of Therapy - Stewardship Principles

Shorter courses are preferred whenever evidence supports equivalent outcomes:
InfectionEvidence-Based Duration
Uncomplicated UTI (women)3 days (TMP-SMX or fluoroquinolone)
UTI in afebrile men7 days (as effective as 14 days)
Community-acquired pneumonia5 days (controlled trial data)
Ventilator-associated pneumonia8 days (vs. 15 days) - except non-fermenters (P. aeruginosa, Acinetobacter)
Gram-negative bacteremia (stable by day 7)7 days (as effective as 14 days)
GonorrheaSingle dose (if susceptible)
  • Goldman-Cecil Medicine, p. 3015-3016

Choosing Wisely - What NOT to Do

The AAP and Pediatric Infectious Diseases Society recommend:
  • Do NOT start empiric antibiotics without first obtaining appropriate cultures (blood, urine, etc.)
  • Do NOT use broad-spectrum agents for perioperative prophylaxis, or continue prophylaxis after wound closure in clean/clean-contaminated procedures
  • Do NOT treat uncomplicated CAP in healthy, immunized hospitalized patients with anything broader than ampicillin
  • Do NOT use vancomycin or carbapenems empirically in neonatal ICU patients without specific risk factors for resistant pathogens
  • Do NOT place PICCs or use prolonged IV antibiotics in children when an oral transition is appropriate
  • Red Book 2021, p. 1329

Stewardship in the Outpatient Setting - What Works and What Doesn't

Proven effective:
  • Provider audit and feedback with peer comparisons
  • "Nudge" posters in clinician workspaces
  • Clinical decision support tools
  • Patient education
  • Communications training
  • Multifaceted (combined) interventions - consistently most effective
Unproven or ineffective:
  • Procalcitonin-guided prescribing in ambulatory settings (unproven)
  • C-reactive protein testing (not durable)
  • Delayed antibiotic prescriptions - Conceptually flawed and should be avoided. They are usually given for viral infections anyway, ignore the self-limited natural history of URIs, shift clinical decision-making onto patients, and send a mixed message
  • Harrison's Principles of Internal Medicine 22E (2025), p. 296-297

Outcome Metrics Tracked by ASPs

  • Antibiotic utilization - Days of therapy (DOT) per 1,000 bed-days; Standardized Antimicrobial Administration Ratio (SAAR) via CDC's NHSN
  • Patient outcomes - Mortality, hospital length of stay
  • Process measures - Appropriateness of prescriptions, IVPO conversion rates
  • Complications - C. difficile infection rates, rates of resistant organisms (MRSA, CRE, VRE, ESBL-producers)

Regulatory and Policy Framework

Multiple national bodies have mandated or strongly supported ASPs:
  • CDC Core Elements (2014, updated 2019 for hospitals; updated 2026 for outpatient)
  • The Joint Commission (TJC) Medication Management Standards
  • CMS Conditions of Participation
  • 2015 National Action Plan for Combating Antibiotic-Resistant Bacteria (US)
  • IDSA/SHEA Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Recent Evidence (2024-2026)

A 2025 systematic review (PMID 39955846, Artificial Intelligence in Medicine) examined AI-driven approaches within ASPs and found that machine learning models can improve prescription appropriateness by integrating patient data, local resistance patterns, and clinical guidelines into real-time decision support. Dental stewardship interventions also show promise (PMID 39400429), with educational and audit-feedback programs reducing unnecessary antibiotic prescribing in dental settings.
Key takeaway: Effective stewardship is not about restricting antibiotics - it is about getting the right antibiotic to the right patient at the right time and stopping it as soon as it is no longer needed. Programs that combine multiple interventions (audit-feedback + clinical decision support + education) consistently outperform single-strategy approaches.
This is a shared conversation. Sign in to Orris to start your own chat.